À LA UNE de la Rhumatologie
-
Neuropathic pain and central sensitization in patients with rheumatoid arthritis attending a tertiary hospital
Chronic pain (CP), defined as pain lasting ≥ 3 months, is a leading cause of disability worldwide, contributing to significant socioeconomic burdens and reduced quality of life [1, 2]. Pain conditions are generally classified into three main phenotypes: nociceptive, neuropathic, and nociplastic. Nociceptive pain arises from the activation of peripheral nociceptors in response to actual or potential... Lire la suite
Advances in Rheumatology 2025; 65(1): 52
-
A retrospective study of 3D-printed custom titanium prostheses for reconstruction of bone defects after resection of pelvic tumors: technical points and...
The pelvis is a common site for malignant bone tumors, and pelvic tumor surgery is a great challenge for bone tumor specialists due to its deep location and complex anatomy, and pelvic tumors are often already large in size and adjacent to complex surrounding organs and blood vessels by the time of the first visit [1, 2]. Prior to the 1980 s, the usual surgical approach for pelvic malignancies... Lire la suite
BMC Surgery 2025; 25(1): 513
-
Impact of HLA-DRB1 SE, anti-citrullinated protein antibodies and smoking on radiographic outcome in Greek patients with Rheumatoid Arthritis
Rheumatoid Arthritis (RA) is a chronic, systemic, autoimmune disease marked by persistent inflammation of synovial joints, leading to progressive joint deformity, functional impairment, disability, and decreased quality of life [1, 2]. Bone erosions typically develop early in the course of RA, sometimes as early as the first year [3]. However, their onset can vary among individuals due to factors such... Lire la suite
BMC Rheumatology 2025; 9(1): 128
-
Efficacy and safety of tofacitinib treatment in Finnish patients with juvenile idiopathic arthritis: a real-life study
Juvenile idiopathic arthritis (JIA) encompasses a heterogeneous group of chronic inflammatory arthritis with unknown origin in children with onset before the age of 16 [1]. This condition is the most common rheumatic disease in childhood, with a global prevalence ranging from 16 to 150 cases per 100,000. Different subtypes are characterised by various clinical features and distributed frequencies [2].... Lire la suite
Arthritis Research & Therapy 2025; 27(1):...
- Consultez les archives
